Brief: Philips Receives FDA 510(K) Clearance For Its Rembra Platform
22/04/2026 14:02
April 22 (Reuters) - Koninklijke Philips NV PHG.AS: PHILIPS RECEIVES FDA 510(K) CLEARANCE FOR ITS REMBRA PLATFORM, EXPANDING ACCESS TO FASTER, MORE PRECISE CT IMAGING ACROSS FRONTLINE CARE AND CANCER TREATMENT PLANNING Source text: ID:nGNX9vyLmd Further company coverage: PHG.AS (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Koninklijke Philips
See all newsBrief: Philips Launches Hypervue Integrated System In The U.S., Bringing Advanced Coronary Imaging And Physiology Into The Cathlab
Citi lifts ResMed's ASX-listed stock's target price after FX, valuation updates
Philips wins Dutch court battle with shareholders over recall
Europe Research Roundup: Allianz, Mercedes-Benz, Tesco
Brief: SA's Competition Commission Refers GE, Siemens, Philips Units To Tribunal For Alleged Anticompetitive Conduct